The decision by US District Judge Denise Cote Friday was part of a civil case brought by the Federal Trade Commission, and attorneys general for New York, California, Ohio, Pennsylvania, Illinois, North Carolina and Virginia in 2020, who alleged Shkreli violated federal and state laws that ban anticompetitive conduct. A week-long trial took place in December, which Shkreli opted not to attend, according to the ruling.
CNN has reached out to attorneys for Shkreli for comment. He is currently serving a prison sentence on unrelated charges at a federal facility in Pennsylvania and is expected to be released in November, according to Bureau of Prisons online records.
New York Attorney General Letita James, representing one of the states that will receive money from the fine, said in a statement the court’s decision puts corporate executives on notice her office is prepared to seek personal accountability for anticompetitive conduct that impedes people’s access to affordable medications.
“The rich and powerful don’t get to play by their own set of rules, so it seems that cash doesn’t rule everything around Mr. Shkreli,” James said in a statement. “New Yorkers can trust that my office will do everything possible to hold the powerful accountable, in addition to fighting to protect their health and their wallets.”